The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer

Breast cancer is the most prevalent cancer in women worldwide. About 15-20% of all breast cancers do not express estrogen receptor, progesterone receptor or HER2 receptor and hence are collectively classified as triple negative breast cancer (TNBC). These tumors are often relatively aggressive when...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Wu, Xinyan, Saddiq, Muhammad Zahari, Renuse, Santosh, Kelkar, Dhanashree S, Barbhuiya, Mustafa A, Rojas, Pamela L, Stearns, Vered, Gabrielson, Edward, Malla, Pavani, Sukumar, Saraswati, Mahajan, Nupam P, Pandey, Akhilesh
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2016
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5356856/
https://ncbi.nlm.nih.gov/pubmed/27902967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13579
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky